Luteoloside suppresses proliferation and metastasis of hepatocellular carcinoma cells by inhibition of NLRP3 inflammasome.

The inflammasome is a multi-protein complex which when activated regulates caspase-1 activation and IL-1β secretion. Inflammasome activation is mediated by NLR proteins that respond to stimuli. Among NLRs, NLRP3 senses the widest array of stimuli. NLRP3 inflammasome plays an important role in the de...

Full description

Bibliographic Details
Main Authors: Shao-hua Fan, Yan-yan Wang, Jun Lu, Yuan-lin Zheng, Dong-mei Wu, Meng-qiu Li, Bin Hu, Zi-feng Zhang, Wei Cheng, Qun Shan
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3935965?pdf=render
_version_ 1811322145328857088
author Shao-hua Fan
Yan-yan Wang
Jun Lu
Yuan-lin Zheng
Dong-mei Wu
Meng-qiu Li
Bin Hu
Zi-feng Zhang
Wei Cheng
Qun Shan
author_facet Shao-hua Fan
Yan-yan Wang
Jun Lu
Yuan-lin Zheng
Dong-mei Wu
Meng-qiu Li
Bin Hu
Zi-feng Zhang
Wei Cheng
Qun Shan
author_sort Shao-hua Fan
collection DOAJ
description The inflammasome is a multi-protein complex which when activated regulates caspase-1 activation and IL-1β secretion. Inflammasome activation is mediated by NLR proteins that respond to stimuli. Among NLRs, NLRP3 senses the widest array of stimuli. NLRP3 inflammasome plays an important role in the development of many cancer types. However, Whether NLRP3 inflammasome plays an important role in the process of hepatocellular carcinoma (HCC) is still unknown. Here, the anticancer effect of luteoloside, a naturally occurring flavonoid isolated from the medicinal plant Gentiana macrophylla, against HCC cells and the underlying mechanisms were investigated. Luteoloside significantly inhibited the proliferation of HCC cells in vitro and in vivo. Live-cell imaging and transwell assays showed that the migration and invasive capacities of HCC cells, which were treated with luteoloside, were significantly inhibited compared with the control cells. The inhibitory effect of luteoloside on metastasis was also observed in vivo in male BALB/c-nu/nu mouse lung metastasis model. Further studies showed that luteoloside could significantly reduce the intracellular reactive oxygen species (ROS) accumulation. The decreased levels of ROS induced by luteoloside was accompanied by decrease in expression of NLRP3 inflammasome resulting in decrease in proteolytic cleavage of caspase-1. Inactivation of caspase-1 by luteoloside resulted in inhibition of IL-1β. Thus, luteoloside exerts its inhibitory effect on proliferation, invasion and metastasis of HCC cells through inhibition of NLRP3 inflammasome. Our results indicate that luteoloside can be a potential therapeutic agent not only as an adjuvant therapy for HCC, but also, in the control and prevention of metastatic HCC.
first_indexed 2024-04-13T13:30:06Z
format Article
id doaj.art-15974f7625d9453eb10b8b438071c3d5
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-13T13:30:06Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-15974f7625d9453eb10b8b438071c3d52022-12-22T02:45:00ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0192e8996110.1371/journal.pone.0089961Luteoloside suppresses proliferation and metastasis of hepatocellular carcinoma cells by inhibition of NLRP3 inflammasome.Shao-hua FanYan-yan WangJun LuYuan-lin ZhengDong-mei WuMeng-qiu LiBin HuZi-feng ZhangWei ChengQun ShanThe inflammasome is a multi-protein complex which when activated regulates caspase-1 activation and IL-1β secretion. Inflammasome activation is mediated by NLR proteins that respond to stimuli. Among NLRs, NLRP3 senses the widest array of stimuli. NLRP3 inflammasome plays an important role in the development of many cancer types. However, Whether NLRP3 inflammasome plays an important role in the process of hepatocellular carcinoma (HCC) is still unknown. Here, the anticancer effect of luteoloside, a naturally occurring flavonoid isolated from the medicinal plant Gentiana macrophylla, against HCC cells and the underlying mechanisms were investigated. Luteoloside significantly inhibited the proliferation of HCC cells in vitro and in vivo. Live-cell imaging and transwell assays showed that the migration and invasive capacities of HCC cells, which were treated with luteoloside, were significantly inhibited compared with the control cells. The inhibitory effect of luteoloside on metastasis was also observed in vivo in male BALB/c-nu/nu mouse lung metastasis model. Further studies showed that luteoloside could significantly reduce the intracellular reactive oxygen species (ROS) accumulation. The decreased levels of ROS induced by luteoloside was accompanied by decrease in expression of NLRP3 inflammasome resulting in decrease in proteolytic cleavage of caspase-1. Inactivation of caspase-1 by luteoloside resulted in inhibition of IL-1β. Thus, luteoloside exerts its inhibitory effect on proliferation, invasion and metastasis of HCC cells through inhibition of NLRP3 inflammasome. Our results indicate that luteoloside can be a potential therapeutic agent not only as an adjuvant therapy for HCC, but also, in the control and prevention of metastatic HCC.http://europepmc.org/articles/PMC3935965?pdf=render
spellingShingle Shao-hua Fan
Yan-yan Wang
Jun Lu
Yuan-lin Zheng
Dong-mei Wu
Meng-qiu Li
Bin Hu
Zi-feng Zhang
Wei Cheng
Qun Shan
Luteoloside suppresses proliferation and metastasis of hepatocellular carcinoma cells by inhibition of NLRP3 inflammasome.
PLoS ONE
title Luteoloside suppresses proliferation and metastasis of hepatocellular carcinoma cells by inhibition of NLRP3 inflammasome.
title_full Luteoloside suppresses proliferation and metastasis of hepatocellular carcinoma cells by inhibition of NLRP3 inflammasome.
title_fullStr Luteoloside suppresses proliferation and metastasis of hepatocellular carcinoma cells by inhibition of NLRP3 inflammasome.
title_full_unstemmed Luteoloside suppresses proliferation and metastasis of hepatocellular carcinoma cells by inhibition of NLRP3 inflammasome.
title_short Luteoloside suppresses proliferation and metastasis of hepatocellular carcinoma cells by inhibition of NLRP3 inflammasome.
title_sort luteoloside suppresses proliferation and metastasis of hepatocellular carcinoma cells by inhibition of nlrp3 inflammasome
url http://europepmc.org/articles/PMC3935965?pdf=render
work_keys_str_mv AT shaohuafan luteolosidesuppressesproliferationandmetastasisofhepatocellularcarcinomacellsbyinhibitionofnlrp3inflammasome
AT yanyanwang luteolosidesuppressesproliferationandmetastasisofhepatocellularcarcinomacellsbyinhibitionofnlrp3inflammasome
AT junlu luteolosidesuppressesproliferationandmetastasisofhepatocellularcarcinomacellsbyinhibitionofnlrp3inflammasome
AT yuanlinzheng luteolosidesuppressesproliferationandmetastasisofhepatocellularcarcinomacellsbyinhibitionofnlrp3inflammasome
AT dongmeiwu luteolosidesuppressesproliferationandmetastasisofhepatocellularcarcinomacellsbyinhibitionofnlrp3inflammasome
AT mengqiuli luteolosidesuppressesproliferationandmetastasisofhepatocellularcarcinomacellsbyinhibitionofnlrp3inflammasome
AT binhu luteolosidesuppressesproliferationandmetastasisofhepatocellularcarcinomacellsbyinhibitionofnlrp3inflammasome
AT zifengzhang luteolosidesuppressesproliferationandmetastasisofhepatocellularcarcinomacellsbyinhibitionofnlrp3inflammasome
AT weicheng luteolosidesuppressesproliferationandmetastasisofhepatocellularcarcinomacellsbyinhibitionofnlrp3inflammasome
AT qunshan luteolosidesuppressesproliferationandmetastasisofhepatocellularcarcinomacellsbyinhibitionofnlrp3inflammasome